
Niluja Thiru
@Niluja5
Followers
443
Following
3K
Media
26
Statuses
1K
Radiation oncologist โก| translational radiobiology| ๐ฆ๐บ๐ฌ๐ง
Joined September 2018
Thanks @BMJOncology for commissioning this editorial so it can be featured together with @nuradh et alโs latest study there https://t.co/yXoJ4MOoF5! Itโs such a pleasure to get to write the editorial with my mates @brachyraqi @medicine98 @Niluja5 ๐
bmjoncology.bmj.com
Objective Since modern radiotherapy techniques such as intensity-modulated radiotherapy (IMRT) pivot on a strategy of dose redistribution, it may increase integral dose and consequently worsening of...
Despite radiotherapy's important role in optimising cancer outcomes, systemic immunological consequences like radiation-induced lymphocytopenia can pose a significant challenge. https://t.co/A49UqiRgRw
0
4
7
Despite radiotherapy's important role in optimising cancer outcomes, systemic immunological consequences like radiation-induced lymphocytopenia can pose a significant challenge. https://t.co/A49UqiRgRw
0
5
13
1/ Thrilled that our paper is out today in @NatureCellBio. A collaboration between WSLHD Radiation Oncology Network and @TheCesareLab led by @szmyd_radoslaw
https://t.co/kUeN0SpNqG
nature.com
Nature Cell Biology - Szmyd et al. show that DNA repair pathways impact whether cells with DNA lesions arrest in mitosis. The formation of homologous recombination-driven double Holliday junctions...
0
8
21
Incredible session chaired by @sandraturner49 on optimising collaboration between #consumers and researchers. Ensuring appropriate #mana and value given to consumer voices and needs. #cancerresearch #cancervoices #TROG2025ASM #TROGCancerResearch @TROGfightcancer @TargetingCancer
0
2
4
A real labour of love, but here it is. #Hypoxia is complex. Does it interact with ADT? Can it predict poor outcomes after long-term follow up? As @ProstateUKProfs say, grab a โ & have a read๐๐ฝ @UoM_DCS @MCRCnews @Niluja5 @CatharineWest3 @DrSpratticus @ChristieLibrary
Can we measure hypoxia to predict how men will respond to #prostatecancer treatments? A team led by @CatharineWest3 and @achoud72 from @UoM_DCS examine this question in a new study in @IJROBP Grab a โ and read: https://t.co/wDU7AsTXGs
1
5
19
@JulieMcCrossin @TROGfightcancer @sundap15 @TargetingCancer @lucindamorris23 @lucindaburke @weeloonong @_ShankarSiva @Niluja5 Not too late to donate. You do so much for @TROGfightcancer anyway Julie ๐ https://t.co/cNQC2NyjIq
0
1
3
As #RANZCR2024 comes to a close, it is my honour to be the RO convenor for #RANZCR2025, with a line-up of esteemed international speakers (more TBC). Please save the date, and see you in Melbourne 23-25 October 2025! @AmarUKishan @SahgalArjun @NiuSanford @fabiomoraesmd
We hope everyone enjoyed the ASM in Perth! Please tag us in any photos or memories from your time there. #RANZCR2024 With many thanks to our sponsors, delegates and all our guests. We look forward to welcoming you next year in Melbourne for #RANZCR2025
3
4
41
So much fun on the gorgeous Blue Mountains @TROGfightcancer fundraising hike yesterday (a few sore muscles today) Thanks to sponsors supporting vital #radonc research @JulieMcCrossin @sundap15 @TargetingCancer @lucindamorris23 @lucindaburke @weeloonong @_ShankarSiva @Niluja5
1
2
17
So proud to see the first published series of paediatric brachytherapy in Australia. Many thanks to all who collaborated on this program ๐ https://t.co/lsqBwphFlr
@TargetingCancer @Niluja5 @sandraturner49 @JPoderMedPhys @AusBrachy @PeterMacCC @WestSydHealth
2
5
19
Hands up for the 2024 Targeting Cancer Fun Run ๐๐โโ๏ธ๐๐ฝโโ๏ธโผ๏ธ #TargetingCancer #RANZCR2024
1
5
12
Thrilled to give the latest #radonc updates at #SIOG2024 #gerionc plenary (๐๐ผand showcase Fastrack II, PACE A&B!๐๐ผ) Take home messages: โก#SABR=proven curative treatment for localised prostate & renal ca โกBladder conservation=SoC โกRT=excellent Rx option for older adults!๐๐ผ
1
15
43
Frailty frameworks and working on different approaches to measure frailty with tools such as ELFI and Fried's frailty index. Use of https://t.co/GjqF0i5DyC can help guide the best tool to use. @KhengSoo1 summarises best approaches for gerionc clinical trials. @SIOGorg #SIOG2024
0
8
12
Australian rad onc @lucindamorris23 highlighted advances in hypofractionation & use of SABR in oligometastases and primary disease positively impacts older patients with cancer both from curative & palliative perspectives. Referrals to rad onc need to improve. @SIOGorg #SIOG2024
0
2
4
Delighted to share the results of #PACE B trial, published in @NEJM today 5 fraction SBRT is non inferior to CRT! https://t.co/9ja6OZFRab
@alison_tree @ICR_CTSU @EmmaHall71 @royalmarsdenNHS @DrAndrewLoblaw @cpeedell @DrTolan @ProfJOSullivan @DrSuneil_PCa
26
161
357
Important look at unanalyzed treatments Off-protocol RT allowed in 52% of trials, predominantly industry sponsored; reported in 2% Associated with higher likelihood of meeting primary endpoint https://t.co/lDHexFph6P
@AlexSherryMD @eugenekoay @ChadTangMD @PavlosMsaouel @ebludmir
1
38
76
GC-RTRO welcomes Honorary Associate Professor Lucinda Morris to our team! As a Radiation Oncologist, educator and researcher, she brings her passion for patient advocacy and radiation therapy to our group. We are excited to have her energy and experience on board. #RadOnc
4
1
32
So enjoyed meeting @PRJeffWhite in person to help create World Radiotherapy/Radiation Therapy Awareness Day #WRAD Sign up using QR/link. Donโt miss out! @lucindamorris23 @ASTRO_org @GlobalRTCo @radiotherapy_uk @TargetingCancer @TROGfightcancer
2
17
33
Wise words fr legendary Howard Sandler @ASTRO_org today ๐บ๐ธ Top tips for #radonc 1. Challenge the cliche โcystectomy is the gold standardโ for curative tmt of bladder cancer. Itโs not. 2. Know your go-to karaoke song just in case you need it! ๐ค๐ต
2
7
17
Prof @achoud72 at the #ASTRO24 Presidential Symposium on #radonc advances transforming the treatment of #bladdercancer. Personalising treatment = critical And let's preserve those precious bladders ๐๐ผ
0
4
20
Worried about toxicity with adjuvant RT post-cystectomy? @VedangMurthy presents #BART trial toxicity results. There is no significant difference. These are high risk patients, 70% had NAC. Paper in @IJROBP Take home to surgeons/radoncs - Don't worry! ๐๐ฝ @docpriyamvada #ASTRO24
2
27
77